These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35848358)

  • 1. CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study.
    Frezza AM; Stacchiotti S; Chibon F; Coindre JM; Italiano A; Romagnosa C; Bagué S; Dei Tos AP; Braglia L; Palmerini E; Quagliuolo V; Broto JM; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Beveridge RD; Lugowska I; Lesluyes T; Maestro R; Merlo FD; Casali PG; Gronchi A
    Cancer Med; 2023 Jan; 12(2):1350-1357. PubMed ID: 35848358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
    Filleron T; Le Guellec S; Chevreau C; Cabarrou B; Lesluyes T; Lodin S; Massoubre A; Mounier M; Poublanc M; Chibon F; Valentin T
    BMC Cancer; 2020 Jul; 20(1):716. PubMed ID: 32736540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
    Pasquali S; Palmerini E; Quagliuolo V; Martin-Broto J; Lopez-Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz-Beveridge R; Ferraresi V; Lugowska I; Infante G; Braglia L; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Miceli R; Casali PG; Gronchi A
    Cancer; 2022 Jan; 128(1):85-93. PubMed ID: 34643947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
    Gronchi A; Palmerini E; Quagliuolo V; Martin Broto J; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz Beveridge R; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Braglia L; Donati DM; Palassini E; Bianchi G; Marrari A; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    J Clin Oncol; 2020 Jul; 38(19):2178-2186. PubMed ID: 32421444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
    Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
    Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.
    Pasquali S; Colombo C; Pizzamiglio S; Verderio P; Callegaro D; Stacchiotti S; Martin Broto J; Lopez-Pousa A; Ferrari S; Poveda A; De Paoli A; Quagliuolo V; Jurado JC; Comandone A; Grignani G; De Sanctis R; Palassini E; Llomboart-Bosch A; Dei Tos AP; Casali PG; Picci P; Gronchi A
    Eur J Cancer; 2018 Apr; 93():28-36. PubMed ID: 29475197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03).
    Jakob J; Lesluyes T; Simeonova-Chergou A; Wenz F; Hohenberger P; Chibon F; Le Guellec S
    Strahlenther Onkol; 2020 Mar; 196(3):280-285. PubMed ID: 31732782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Stratification Tools to Aid Decisions on Adjuvant Chemotherapy Usage in Resected Soft Tissue Sarcomas: A Ten-Year Review of an Irish Sarcoma Center Experience.
    Weadick CS; Goggin C; Keogh RJ; Murphy JF; Feeley L; Bennett MW; O'Reilly S; Redmond HP; Kelly J; O'Mahony D; Noonan S; Clover AJP; Bambury RM
    World J Oncol; 2024 Aug; 15(4):640-647. PubMed ID: 38993253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond.
    Chibon F; Lesluyes T; Valentin T; Le Guellec S
    Genes Chromosomes Cancer; 2019 Feb; 58(2):124-129. PubMed ID: 30387235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303.
    De Sanctis R; Giordano L; Colombo C; De Paoli A; Navarria P; Sangalli C; Buonadonna A; Sanfilippo R; Bertola G; Fiore M; Marrari A; Navarria F; Bertuzzi A; Casali PG; Basso S; Santoro A; Quagliuolo V; Gronchi A
    Ann Surg Oncol; 2017 Dec; 24(13):3872-3879. PubMed ID: 29043525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
    Le Guellec S; Lesluyes T; Sarot E; Valle C; Filleron T; Rochaix P; Valentin T; Pérot G; Coindre JM; Chibon F
    Ann Oncol; 2018 Aug; 29(8):1828-1835. PubMed ID: 29860427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
    Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
    Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study.
    Martin-Broto J; Gutierrez AM; Ramos RF; Lopez-Guerrero JA; Ferrari S; Stacchiotti S; Picci P; Calabuig S; Collini P; Gambarotti M; Bague S; Dei Tos AP; Palassini E; Luna P; Cruz J; Cubedo R; Martinez-Trufero J; Poveda A; Casali PG; Fernandez-Serra A; Lopez-Pousa A; Gronchi A
    Mol Cancer Ther; 2014 Jan; 13(1):249-59. PubMed ID: 24145283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature.
    Bertucci F; Niziers V; de Nonneville A; Finetti P; Mescam L; Mir O; Italiano A; Le Cesne A; Blay JY; Ceccarelli M; Bedognetti D; Birnbaum D; Mamessier E
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).
    Gronchi A; Palmerini E; Quagliuolo V; Martin Broto J; Lopez Pousa A; Grignani G; Brunello A; Blay JY; Tendero O; Diaz Beveridge R; Ferraresi V; Lugowska I; Pizzamiglio S; Verderio P; Fontana V; Donati DM; Palassini E; Sanfilippo R; Bianchi G; Bertuzzi A; Morosi C; Pasquali S; Stacchiotti S; Bagué S; Coindre JM; Miceli R; Dei Tos AP; Casali PG
    J Clin Oncol; 2024 Mar; 42(8):898-906. PubMed ID: 38232337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA sequencing validation of the Complexity INdex in SARComas prognostic signature.
    Lesluyes T; Pérot G; Largeau MR; Brulard C; Lagarde P; Dapremont V; Lucchesi C; Neuville A; Terrier P; Vince-Ranchère D; Mendez-Lago M; Gut M; Gut I; Coindre JM; Chibon F
    Eur J Cancer; 2016 Apr; 57():104-11. PubMed ID: 26916546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
    Bertucci F; De Nonneville A; Finetti P; Perrot D; Nilbert M; Italiano A; Le Cesne A; Skubitz KM; Blay JY; Birnbaum D
    Ann Oncol; 2018 Feb; 29(2):459-465. PubMed ID: 29069276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial.
    Martin-Broto J; Lopez-Alvarez M; Moura DS; Ramos R; Collini P; Romagosa C; Bagué S; Renne SL; Barisella M; Velasco V; Coindre JM; Lopez-Lopez D; Dopazo J; Gambarotti M; Braglia L; Merlo DF; Palmerini E; Stacchiotti S; Quagliuolo VL; Lopez-Pousa A; Grignani G; Blay JY; Brunello A; Gutierrez A; Valverde C; Hindi N; Dei Tos AP; Picci P; Casali PG; Gronchi A
    Mol Cancer Ther; 2021 Dec; 20(12):2539-2552. PubMed ID: 34552008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.